Caldan Therapeutics

Calyx Therapeutics

This company develops oral therapies for diabetes and inflammatory diseases using natural plant extracts for pharmaceutical and biotechnology organisations.

Melacure Therapeutics AB

This biotechnology company develops small molecule drugs targeting melanocortin receptors to treat metabolic, inflammatory and skin disorders for the pharmaceutical industry.

Carmot Therapeutics

This biotechnology company develops drug therapies to treat metabolic diseases, such as obesity and diabetes, for patients with these conditions.

Metabolys

This biopharmaceutical company develops oral small molecules to treat metabolic diseases, specifically non-alcoholic steatohepatitis and type 2 diabetes, for the global healthcare market.

AdipoPharma

This clinical-stage biotechnology company develops therapeutic peptides to treat insulin resistance and type 2 diabetes for patients with metabolic disorders.

Caspian Therapeutics

The company develops small-molecule menin inhibitors to restore insulin production in patients with diabetes and cardiometabolic diseases.

Hawkhill Therapeutics

This company develops oral small molecule therapies for obesity and metabolic health to preserve muscle mass for the biotechnology and pharmaceutical sectors.

Eternygen

This biopharmaceutical company develops small molecule inhibitors targeting metabolic diseases, such as fatty liver and diabetes, for patients needing novel medical treatments.